Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Ischaemic Neuropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT01607671
What this trial is testing

Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

Who this might be right for
Optic Neuropathy, IschemicAnterior Ischemic Optic NeuropathyIschemic Optic Neuropathy+1 more
Fraser Health
Not applicableLooking for participantsNCT05749094
What this trial is testing

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisAnterior Ischemic Optic NeuropathyOptic Neuropathy, Ischemic
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 285
Not applicableEnded earlyNCT00969956
What this trial is testing

Time To Complications Occurs in Diabetes

Who this might be right for
RetinopathyNephropathyDiabetic Neuropathy+2 more
Karolinska Institutet 17
Not applicableNot Yet RecruitingNCT07075887
What this trial is testing

Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study

Who this might be right for
Neuro-OphthalmologyOptic NeuropathiesOptic Atrophy, Hereditary, Leber+3 more
Barboni 70
Testing effectiveness (Phase 2)Study completedNCT02045212
What this trial is testing

Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).

Who this might be right for
Non-arteritic Ischemic Optic NeuropathyOptic Nerve Injuries
Regenera Pharma Ltd 22
Not applicableStudy completedNCT00759174
What this trial is testing

Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION

Who this might be right for
Optic Neuropathy, Ischemic
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 673
Not applicableUnknownNCT05353413
What this trial is testing

Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.

Who this might be right for
Ischemic Optic NeuropathyOptic NeuritisCompressive Optic Neuropathy+3 more
Medical University of Bialystok 20
Testing effectiveness (Phase 2)UnknownNCT00813059
What this trial is testing

Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Non-arteritic Anterior Ischemic Optic Neuropathy
Mount Sinai Hospital, Canada 10
Post-approval studies (Phase 4)Study completedNCT00432393
What this trial is testing

Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Shahid Beheshti University of Medical Sciences
Not applicableStudy completedNCT01131104
What this trial is testing

Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Eli Lilly and Company 345
Not applicableStudy completedNCT02643615
What this trial is testing

Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery

Who this might be right for
Ischemic Optic Neuropathy
Ohio State University 20
Not applicableUnknownNCT01768260
What this trial is testing

Effect of EECP on Anterior Ischemic Optic Neuropathy

Who this might be right for
Anterior Ischemic Optic Neuropathy
First Affiliated Hospital, Sun Yat-Sen University 40
Early research (Phase 1)Study completedNCT00561834
What this trial is testing

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
University of Colorado, Denver 2
Not applicableStudy completedNCT05305079
What this trial is testing

NA-AION Risk Factors: New Perspectives

Who this might be right for
Non-arteritic Ischemic Optic NeuropathyOptic Disk Drusen
Rigshospitalet, Denmark 179
Large-scale testing (Phase 3)UnknownNCT02377271
What this trial is testing

ENDOTHELION Study Group: Effect of Bosentan in NAION Patients

Who this might be right for
Ischemic Optic Neuropathy
University Hospital, Grenoble 86
Not applicableLooking for participantsNCT04451265
What this trial is testing

Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

Who this might be right for
Neuro-Ophthalmology
Fondation Ophtalmologique Adolphe de Rothschild 250
Not applicableUnknownNCT00000126
What this trial is testing

Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)

Who this might be right for
Ischemic Optic Neuropathy
National Eye Institute (NEI)
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Post-approval studies (Phase 4)Study completedNCT03046693
What this trial is testing

Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non-arteritic Anterior Ischemic Optic Neuropathy
Valen Chia 38
Next Page